© 1992 Oxford University Press
RESEARCH-ARTICLE |
Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters

MRC Molecular Neurobiology Unit, University of Cambridge Medical School Hills Road, Cambridge CB2 2QH 1Imperial Cancer Research Fund Laboratories, Institute of Molecular Medicine, John Radcliffe Hospital Headington, Oxford OX3 9DU, UK
*To whom correspondence should be addressed at present address: Molecular Neurobiology Unit, Royal Free Hospital School of Medicine, Rowland Hill Street, London NW3 2PF, UK
Received July 7, 1992; Revised August 24, 1992; Accepted August 24, 1992
Cognitive impairment occurs in one-third of patients with Duchenne muscular dystrophy, a lethal X-linked, recessive disease caused by mutations in the dystrophin gene which is expressed in both brain and muscle, the two transcripts having alternative first exons. Previous reports have indicated that the brain-type dystrophin transcript predominates in brain. Using in situ hybridisation with antisense oligonucleotides, expression of four distinct mRNAs in specific brain areas is demonstrated here; the 14 kb muscle-type and brain-type transcripts were found to coexist in cortical and hippocampal neurons and two new transcripts have been identified in dentate gyrus and cerebellar Purkinje neurons, respectively. The latter has a novel first exon which was isolated and sequenced from mouse and human, and which would encode a protein with a different amino-terminus from the known muscle- and brain-type isoforms. Mapping in human located this exon in a large intron between the muscle-type promoter and second exon of the dystrophin gene. This finding of four alternative transcripts regulated by different promoters in brain reveals a new complexity to dystrophin expression that may have important insights for mental retardation mechanisms.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Kimura, M. Ikezawa, S. Ozasa, K. Ito, H. Ueno, K. Yoshioka, S. Ijiri, K. Nomura, K. Nakamura, M. Matuskura, et al. Novel Mutation in Splicing Donor of Dystrophin Gene First Exon in a Patient With Dilated Cardiomyopathy but No Clinical Signs of Skeletal Myopathy J Child Neurol, July 1, 2007; 22(7): 901 - 906. [Abstract] [PDF] |
||||
![]() |
T. Yokota, Q.-L. Lu, J. E. Morgan, K. E. Davies, R. Fisher, S. Takeda, and T. A. Partridge Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration J. Cell Sci., July 1, 2006; 119(13): 2679 - 2687. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Chakkalakal, J. Thompson, R. J. Parks, and B. J. Jasmin Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies FASEB J, June 1, 2005; 19(8): 880 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. de Leon, C. Montanez, P. Gomez, S. L. Morales-Lazaro, V. Tapia-Ramirez, V. Valadez-Graham, F. Recillas-Targa, D. Yaffe, U. Nudel, and B. Cisneros Dystrophin Dp71 Expression Is Down-regulated during Myogenesis: ROLE OF Sp1 AND Sp3 ON THE Dp71 PROMOTER ACTIVITY J. Biol. Chem., February 18, 2005; 280(7): 5290 - 5299. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. De Repentigny, P. Marshall, R. G. Worton, and R. Kothary The mouse dystrophin muscle enhancer-1 imparts skeletal muscle, but not cardiac muscle, expression onto the dystrophin Purkinje promoter in transgenic mice Hum. Mol. Genet., November 15, 2004; 13(22): 2853 - 2862. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Weickert, R. E. Straub, B. W. McClintock, M. Matsumoto, R. Hashimoto, T. M. Hyde, M. M. Herman, D. R. Weinberger, and J. E. Kleinman Human Dysbindin (DTNBP1) Gene Expression in Normal Brain and in Schizophrenic Prefrontal Cortex and Midbrain Arch Gen Psychiatry, June 1, 2004; 61(6): 544 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Pozzoli, G. Elgar, R. Cagliani, L. Riva, G. P. Comi, N. Bresolin, A. Bardoni, and M. Sironi Comparative Analysis of Vertebrate Dystrophin Loci Indicate Intron Gigantism as a Common Feature Genome Res., May 1, 2003; 13(5): 764 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Guyon, A. N. Mosley, Y. Zhou, K. F. O'Brien, X. Sheng, K. Chiang, A. J. Davidson, J. M. Volinski, L. I. Zon, and L. M. Kunkel The dystrophin associated protein complex in zebrafish Hum. Mol. Genet., March 15, 2003; 12(6): 601 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Blake, A. Weir, S. E. Newey, and K. E. Davies Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle Physiol Rev, April 1, 2002; 82(2): 291 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bastianutto, J. A. Bestard, K. Lahnakoski, D. Broere, M. De Visser, M. Zaccolo, T. Pozzan, A. Ferlini, F. Muntoni, T. Patarnello, et al. Dystrophin muscle enhancer 1 is implicated in the activation of non-muscle isoforms in the skeletal muscle of patients with X-linked dilated cardiomyopathy Hum. Mol. Genet., November 1, 2001; 10(23): 2627 - 2635. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. FRIGERI, G. P. NICCHIA, B. NICO, F. QUONDAMATTEO, R. HERKEN, L. RONCALI, and M. SVELTO Aquaporin-4 deficiency in skeletal muscle and brain of dystrophic mdx mice FASEB J, January 1, 2001; 15(1): 90 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Felisari, F. M. Boneschi, A. Bardoni, M. Sironi, G. P. Comi, M. Robotti, A. C. Turconi, M. Lai, G. Corrao, and N. Bresolin Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy Neurology, August 22, 2000; 55(4): 559 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Burton, J. M. Tinsley, P. J. Holzfeind, N. R. Rodrigues, and K. E. Davies A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy PNAS, November 23, 1999; 96(24): 14025 - 14030. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Holzfeind, H. J. Ambrose, S. E. Newey, R. A. Nawrotzki, D. J. Blake, and K. E. Davies Tissue-selective Expression of alpha -Dystrobrevin Is Determined by Multiple Promoters J. Biol. Chem., March 5, 1999; 274(10): 6250 - 6258. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kimura, S. Fujishita, M. Ikezawa, M. Ogawa, K. Abe, and T. Miike Muscle Type Promoter and Its First Intron Abnormalities in Dystrophin Gene in Patients With Duchenne Muscular Dystrophy J Child Neurol, June 1, 1998; 13(6): 290 - 292. [PDF] |
||||
![]() |
D. J. Blake, R. Nawrotzki, N. Y. Loh, D. C. Gorecki, and K. E. Davies beta -dystrobrevin, a member of the dystrophin-related protein family PNAS, January 6, 1998; 95(1): 241 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ortiz-Lopez, H. Li, J. Su, V. Goytia, and J. A. Towbin Evidence for a Dystrophin Missense Mutation as a Cause of X-Linked Dilated Cardiomyopathy Circulation, May 20, 1997; 95(10): 2434 - 2440. [Abstract] [Full Text] |
||||
![]() |
M. L. Oster-Granite, D. L. McPhie, J. Greenan, and R. L. Neve Age-Dependent Neuronal and Synaptic Degeneration in Mice Transgenic for the C Terminus of the Amyloid Precursor Protein J. Neurosci., November 1, 1996; 16(21): 6732 - 6741. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Adams, T. M. Dwyer, L. L. Dowler, R. A. White, and S. C. Froehner Mouse alpha1- and beta2-Syntrophin Gene Structure, Chromosome Localization, and Homology with a Discs Large Domain J. Biol. Chem., October 27, 1995; 270(43): 25859 - 25865. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Marshall, N. Chartrand, and R. G. Worton The Mouse Dystrophin Enhancer Is Regulated by MyoD, E-box-binding Factors, and by the Serum Response Factor J. Biol. Chem., June 1, 2001; 276(23): 20719 - 20726. [Abstract] [Full Text] [PDF] |
||||











